Highlights from ACR Convergence 2023

 

Highlights from ACR Convergence 2023
A

​​ACR Convergence 2023 Highlights: INVIGORATE-1 - Secukinumab for Treatment of Active axSpA as Discussed by Dr. Atul Deodhar

By Highlights from ACR Convergence 2023 FEATURING Atul Deodhar
By Highlights from ACR Convergence 2023 FEATURING Atul Deodhar
88 views
December 11, 2023
0 Comments
Login to view comments. Click here to Login
Spondyloarthropathies
06:48
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: The Burden of Oligoarticular Psoria…

Feat. D. Gladman
16:37
Highlights from ACR Convergence 2023

​​ACR Convergence 2023 Highlights: INVIGORATE-1 - Secukinumab for Tr…

Feat. A. Deodhar
10:23
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Opioid Prescription Rates in Patien…

Feat. H. Berk Degirmenci
09:27
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Interpretation of Disease-Specific …

Feat. X. Baraliakos
07:30
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Efficacy and Safety of Intravenous …

Feat. A. Kivitz
16:19
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Spondyloarthritis - Comparing Adult…

Feat. H. Srinivasalu
06:14
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: The Use of the ASAS Referral Criter…

Feat. A. Chan
16:43
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: 2023 Classification Criteria for Ax…

Feat. P. Weiss
13:18
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: The Yield of Repeated Assessments i…

Feat. M. Marques
10:05
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Results of an Exploratory Analysis …

Feat. M. D'Agostino
11:18
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Clinical Consequences of Infliximab…

Feat. M. Brun
05:25
RheumNow

​​ACR Convergence 2023 Highlights: INVIGORATE-1 Study: IV Secukinuma…

Feat. A. Deodhar
07:03
RheumNow

ACR Convergence 2023 Highlights: Correlation Between Patient and Phy…

Feat. A. Chan, A. Maroof
08:29
RheumNow

ACR Convergence 2023 Highlights: Using Telemedicine to Improve Diagn…

Feat. A. Chan, D. Poddubnyy
04:28
RheumNow

ACR Convergence 2023 Highlights: Deep Neural Networks and Radiograph…

Feat. A. Chan
04:53
RheumNow

ACR Convergence 2023 Highlights: Undiagnosed IBD in AxSpA

Feat. E. Dein
04:41
RheumNow

ACR Convergence 2023 Highlights: The FOREMOST Study: Apremilast in P…

Feat. P. Nash
04:16
RheumNow

ACR Convergence 2023 Highlights: Difficult to Treat axSpA

Feat. P. Nash
07:04
RheumNow

ACR Convergence 2023 Highlights: Imaging Updates in SpA

Feat. R. Tate, C. Blakewell
08:43
RheumNow

ACR Convergence 2023 Highlights: Teledidactic vs On Campus Training …

Feat. A. Chan, V. Schäfer
05:14
RheumNow

ACR Convergence 2023 Highlights: Treatments in SpA

Feat. R. Tate, C. Blakewell
04:08
RheumNow

ACR Convergence 2023 Highlights: Bimekizumab in Active AS: 5 Year St…

Feat. A. Deodhar
04:52
RheumNow

ACR Convergence 2023 Highlights: SpaA Updates: Anti-infliximab Antib…

Feat. E. Dein
48:24
RheumNow

ACR Convergence 2023 Highlights: SpA Topic Panel

Feat. S. Reyes, R. Tate, A. Chan, B. Mehta, J. Cush
33:00
RheumNow

ACR Convergence 2023 Highlights: JAK TYK2 Topic Panel

Feat. J. Cush, J. Pope, M. Putman, D. Liew
05:29
RheumNow

ACR Convergence 2023 Highlights: Two Studies: TAK-279 (Tyk2) in PsA …

Feat. G. Valenzuela